Summary Information:
Meridian Bioscience Inc. Common Stock
NASDAQ:VIVO


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Meridian Bioscience Inc. Common Stock
Exchange: NASDAQ
Symbol: VIVO
SEC CIK: 0000794172
Phone: 5132713700
3471 RIVER HILLS DR
CINCINNATI OH 45244

CEO: John Kenny
Price when page updated: 33.97 Date: 2023-02-01
Company Website:
www.meridianbioscience.com

_Description: Meridian Bioscience Inc. is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products.The company is dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, Meridian provides critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, Meridian provides diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. The company builds relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

IPO YEAR:
1986
Sector:
Health Care
Industry:
Biotechnology: In Vitro & In Vivo Diagnostic Substances
ADRTSO:

MarketCap:
1488831011.00
Beta:
0.815333294323994
52 Week High:
30.65
52 Week Low:
17
52 Week Change:
0.04279749478079342
Short Interest:

Short Date:

Shares Outstanding:
43364448
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
10 Nov 2022
Float:
0
return on Equity:
12.30%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
3.24
Revenue:
$6.758M
Gross Profit:

Cash:

Debt:

Institution Percent:
97.10%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.70%
Return on Assets:
9.40%
Return on Capital:

Profit Margin:
12.60%
Price to Sales:
4.11
Price To Book:
3.81
Short Ratio:
5.94
PE Ratio:
6.066783866007534
Employees:
750
1Y Guesstimate
36.150:1.0:2




__The following are links to various summary and news pages for
__Meridian Bioscience Inc. Common Stock [ VIVO ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-02-01